Header Logo

Connection

TAO WU to Lymphoma, T-Cell

Back to Details
This is a "connection" page, showing publications TAO WU has written about Lymphoma, T-Cell.
TAO WU
Connection Strength
0.206
Lymphoma, T-Cell
  1. Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol. Future Oncol. 2024 Feb; 20(5):245-256.
    View in: PubMed
    Score: 0.206
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.